Sigyn Therapeutics (SIGY) News Today → Move Your Money Before May 1 (From Stansberry Research) (Ad) Free SIGY Stock Alerts $5.75 0.00 (0.00%) (As of 04/25/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineCritical Survey: Quipt Home Medical (NASDAQ:QIPT) and Sigyn Therapeutics (OTCMKTS:SIGY)americanbankingnews.com - April 22 at 1:26 AMSigyn Therapeutics™ to Present at Tomorrow’s Emerging Growth Conferencefinance.yahoo.com - March 5 at 1:21 PMSigyn Therapeutics to Present at Tomorrow's Emerging Growth Conferencefinance.yahoo.com - March 5 at 1:21 PMSigyn Therapeutics™ to Present at Tomorrow's Emerging Growth Conferenceglobenewswire.com - March 5 at 9:00 AMSigyn Therapeutics™ Announces Filing of 2023 Annual Report on SEC Form 10-Kglobenewswire.com - February 21 at 8:45 AMSigyn Therapeutics, Inc.: Sigyn Therapeutics Completes Reverse Stock Splitfinanznachrichten.de - February 3 at 12:29 AMSigyn Therapeutics Announces 1-for-40 Reverse Stock Splitmsn.com - February 2 at 12:35 AMSigyn Therapeutics Completes Reverse Stock Splitfinance.yahoo.com - February 1 at 7:34 PMSigyn Therapeutics, Inc.: Sigyn Therapeutics Announces Reverse Stock Splitfinanznachrichten.de - January 30 at 1:10 PMSigyn Therapeutics, Inc.: Sigyn Therapeutics Releases Letter to Shareholdersfinanznachrichten.de - January 30 at 1:10 PMEQS-News: Sigyn Therapeutics Announces Reverse Stock Splitmarkets.businessinsider.com - January 30 at 1:10 PMSigyn Therapeutics Announces Reverse Stock Splitfinance.yahoo.com - January 30 at 1:10 PMSigyn Therapeutics Releases Letter to Shareholdersfinance.yahoo.com - January 4 at 10:04 AMSigyn Therapeutics, Inc.: Sigyn Therapeutics Announces Appointment of Jerry DeCiccio as Chief Financial Officerfinanznachrichten.de - December 12 at 1:44 PMSigyn Therapeutics appoints Jerry DeCiccio as finance chiefmsn.com - December 12 at 1:44 PMSigyn Therapeutics Announces Appointment of Jerry DeCiccio as Chief Financial Officerfinance.yahoo.com - December 12 at 8:44 AMSigyn Therapeutics, Inc.: Sigyn Therapeutics Reports Third Quarter 2023 Financial Resultsfinanznachrichten.de - November 15 at 9:27 PMSigyn Therapeutics Inc GAAP EPS of -$0.02msn.com - November 15 at 11:26 AMSigyn Therapeutics Reports Third Quarter 2023 Financial Resultsfinance.yahoo.com - November 14 at 5:42 PMSigyn Therapeutics™ Discloses PCT Patent Submission to Enhance Chemotherapy Delivery and Reduce Cancer Treatment Toxicityfinance.yahoo.com - October 4 at 10:21 AMSigyn Therapeutics to Present at Today’s Emerging Growth Conference and Tomorrow at the National Investment Bankers Association Conferencefinance.yahoo.com - September 15 at 8:19 AMRelay Therapeutics Inc Ordinary Sharesmorningstar.com - June 23 at 9:00 AMBeam Therapeutics (NASDAQ: BEAM)fool.com - May 22 at 12:19 AMSigyn Therapeutics Discloses “DEVICES FOR ENHANCING THE ACTIVITY OF THERAPEUTIC ANTIBODIES” Patent Submission and Related ImmunePrep™ Trademark Applicationfinance.yahoo.com - May 17 at 7:58 AMSigyn Therapeutics, Inc.: Sigyn Therapeutics Reports First Quarter 2023 Financial Resultsfinanznachrichten.de - May 16 at 8:31 AMSigyn Therapeutics Reports First Quarter 2023 Financial Resultsfinance.yahoo.com - May 16 at 8:31 AMSigyn Therapeutics™ Announces Appointment of Annette Marleau, Ph.D. as Chief Scientific Officerfinance.yahoo.com - April 11 at 8:36 AMSigyn Therapeutics Announces Filing of 2022 Annual Report on SEC Form 10-Kfinance.yahoo.com - March 31 at 1:04 PMChinook Therapeuticsforbes.com - March 21 at 10:53 PMJounce Therapeutics downgraded to market perform at Raymond James on company restructuringseekingalpha.com - February 25 at 9:44 PM Get Sigyn Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SIGY and its competitors with MarketBeat's FREE daily newsletter. Email Address Move Your Money Before May 1 (Ad)Did you know that the IRS has allegedly been using AI to spy on the bank accounts of American citizens? Click here to get the full story before May 1. SIGY Media Mentions By Week SIGY Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SIGY News Sentiment▼0.000.33▲Average Medical News Sentiment SIGY News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SIGY Articles This Week▼10▲SIGY Articles Average Week Get Sigyn Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SIGY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Plus Therapeutics News Intelligent Bio Solutions News Vivos Therapeutics News NeuroMetrix News ProSomnus News Vapotherm News Avinger News Arch Therapeutics News Sharps Technology News Venus Concept News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:SIGY) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchBiden out June 13; Kamala won’t replace him?Paradigm PressThe only accurate crypto trading system I know …Weiss RatingsBetter than Bitcoin? The Biotech Stock with 46,751% PotentialBehind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sigyn Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
